Tag Archives: phase 3 trial

Abrysvo RSV Vaccine Shows Promise for At-Risk Adults: Phase 3 Trial Results

Pfizer's Abrysvo RSV vaccine shows promise in a phase 3 trial for at-risk adults aged.....Read more